Rheumatic diseases and obesity: Adipocytokines as potential comorbidity biomarkers for cardiovascular diseases

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Scrivo, Rossana ^a   Vasile, Massimiliano ^a,b   Müller Ladner, Ulf ^b   Neumann, Elena ^b   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ANIMAL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; COMORBIDITY; HUMAN; OBESITY; OSTEOARTHRITIS; PHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS;

ADIPOKINES; ANIMALS; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COMORBIDITY; HUMANS; OBESITY; OSTEOARTHRITIS;

EID: 84893819187     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/808125     Document Type: Review

References (127)

1. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003 112 12 1796 1808 2-s2.0-0348230958 10.1172/JCI200319246 (Pubitemid 38063703)
2. Tilg H., Moschen A. R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 2006 6 10 772 783 2-s2.0-33748992313 10.1038/nri1937 (Pubitemid 44453463)
3. Martin S. S., Qasim A., Reilly M. P., Leptin resistance. A possible interface of inflammation and metabolism in obesity-related cardiovascular disease. Journal of the American College of Cardiology 2008 52 15 1201 1210 2-s2.0-52949129178 10.1016/j.jacc.2008.05.060
4. Luk T., Malam Z., Marshall J. C., Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. Journal of Leukocyte Biology 2008 83 4 804 816 2-s2.0-44449124774 10.1189/jlb.0807581 (Pubitemid 351959859)
5. Blüher M., Do adipokines link obesity to its related metabolic and cardiovascular diseases? Clinical Lipidology 2010 5 1 95 107 2-s2.0-77649157988 10.2217/clp.09.86
6. Bays H. E., 'Sick fat,' metabolic disease, and atherosclerosis. The American Journal of Medicine 2009 122 supplement 1 S26 S37 2-s2.0-57749093663 10.1016/j.amjmed.2008.10.015
7. Jenkins M., Flynn A., Smart T., Harbron C., Sabin T., Ratnayake J., Delmar P., Herath A., Jarvis P., Matcham J., A statistician's perspective on biomarkers in drug development. Pharmaceutical Statistics 2011 10 6 494 507 2-s2.0-84855192071 10.1002/pst.532
8. Crowson C. S., Matteson E. L., Davis J. M. III, Gabriel S. E., Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care and Research 2013 65 1 71 77 10.1002/acr.21660
9. Ajeganova, Andersson M. L., Hafström I., BARFOT Study Group, Obesity is associated with worse disease severity in rheumatoid arthritis as well as with co-morbidities-a long-term follow-up from disease onset. Arthritis Care and Research 2013 65 1 78 87 10.1002/acr.21710
10. Lohmander L. S., de Verdier M. G., Rollof J., Nilsson P. M., Engström G., Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Annals of the Rheumatic Diseases 2009 68 4 490 496 2-s2.0-65249176782 10.1136/ard.2008.089748
11. World Health Organization, Health Topics: Obesity 2011 Geneva, Switzerland World Health Organization. http://www.who.int/topics/obesity/en/
12. van Gaal L. F., Mertens I. L., de Block C. E., Mechanisms linking obesity with cardiovascular disease. Nature 2006 444 7121 875 880 2-s2.0-33845914986 10.1038/nature05487 (Pubitemid 46028447)
13. Leroith D., Novosyadlyy R., Gallagher E. J., Lann D., Vljayakumar A., Yakar S., Obesity and Type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Experimental and Clinical Endocrinology and Diabetes 2008 116 supplement 1 S4 S6 2-s2.0-54549094827 10.1055/s-2008-1081488
14. Blüher M., Adipose tissue dysfunction in obesity. Experimental and Clinical Endocrinology and Diabetes 2009 117 6 241 250 2-s2.0-68849132248 10.1055/s-0029-1192044
15. Sarraf P., Frederich R. C., Turner E. M., Ma G., Jaskowiak N. T., Rivet D. J. III, Flier J. S., Lowell B. B., Fraker D. L., Alexander H. R., Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. Journal of Experimental Medicine 1997 185 1 171 175 2-s2.0-17344384196 10.1084/jem.185.1.171 (Pubitemid 27039451)
16. Ahima R. S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., Flier J. S., Role of leptin in the neuroendocrine response to fasting. Nature 1996 382 6588 250 252 2-s2.0-0029896530 10.1038/382250a0 (Pubitemid 26251358)
17. Hotta K., Funahashi T., Bodkin N. L., Ortmeyer H. K., Arita Y., Hansen B. C., Matsuzawa Y., Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001 50 5 1126 1133 2-s2.0-0035039227 (Pubitemid 32374544)
18. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., Furuyama N., Kondo H., Takahashi M., Arita Y., Komuro R., Ouchi N., Kihara S., Tochino Y., Okutomi K., Horie M., Takeda S., Aoyamaa T., Funahashi T., Matsuzawa Y., Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Medicine 2002 8 7 731 737 2-s2.0-0036063777 10.1038/nm724 (Pubitemid 34778727)
19. Patel L., Buckels A. C., Kinghorn I. J., Murdock P. R., Holbrook J. D., Plumpton C., Macphee C. H., Smith S. A., Resistin is expressed in human macrophages and directly regulated by PPAR γ activators. Biochemical and Biophysical Research Communications 2003 300 2 472 476 2-s2.0-0037427540 10.1016/S0006-291X(02)02841-3 (Pubitemid 38375833)
20. Curat C. A., Wegner V., Sengenès C., Miranville A., Tonus C., Busse R., Bouloumié A., Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006 49 4 744 747 2-s2.0-33644826101 10.1007/s00125-006-0173-z (Pubitemid 43357549)
21. Stastny J., Bienertova-Vasku J., Vasku A., Visfatin and its role in obesity development. Diabetes and Metabolic Syndrome 2012 6 2 120 124 10.1016/j.dsx.2012.08.011
22. Chen M. P., Chung F. M., Chang D. M., Tsai J. C., Huang H., Shin S., Lee Y., Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2006 91 1 295 299 2-s2.0-30344471828 10.1210/jc.2005-1475 (Pubitemid 43069152)
23. Steppan C. M., Bailey S. T., Bhat S., Brown E. J., Banerjee R. R., Wright C. M., Patel H. R., Ahima R. S., Lazar M. A., The hormone resistin links obesity to diabetes. Nature 2001 409 6818 307 312 2-s2.0-0035905758 10.1038/35053000 (Pubitemid 32151228)
24. Rangwala S. M., Rich A. S., Rhoades B., Shapiro J. S., Obici S., Rossetti L., Lazar M. A., Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 2004 53 8 1937 1941 2-s2.0-3242806013 10.2337/diabetes.53.8.1937 (Pubitemid 38970738)
25. Friedman J. M., Leptin and the regulation of body weight. Keio Journal of Medicine 2011 60 1 1 9 2-s2.0-79955701330 10.2302/kjm.60.1
26. Boden G., Chen X., Mozzoli M., Ryan I., Effect of fasting on serum leptin in normal human subjects. Journal of Clinical Endocrinology and Metabolism 1996 81 9 3419 3423 2-s2.0-0029844267 10.1210/jc.81.9.3419 (Pubitemid 26296227)
27. Kolaczynski J. W., Ohannesian J. P., Considine R. V., Marco C. C., Caro J. F., Response of leptin to short-term and prolonged overfeeding in humans. Journal of Clinical Endocrinology and Metabolism 1996 81 11 4162 4165 2-s2.0-0029794957 10.1210/jc.81.11.4162 (Pubitemid 26380434)
28. Boden G., Chen X., Kolaczynski J. W., Polansky M., Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. Journal of Clinical Investigation 1997 100 5 1107 1113 2-s2.0-0030883332 (Pubitemid 27386294)
29. Ahima R. S., Flier J. S., Leptin. Annual Review of Physiology 2000 62 413 437 2-s2.0-0033852765 10.1146/annurev.physiol.62.1.413 (Pubitemid 30618269)
30. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., Nagaretani H., Matsuda M., Komuro R., Ouchi N., Kuriyama H., Hotta K., Nakamura T., Shimomura I., Matsuzawa Y., PPAR γ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001 50 9 2094 2099 2-s2.0-0035462629 (Pubitemid 33643677)
31. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 1 79 83 2-s2.0-0033515761 10.1006/bbrc.1999.0255 (Pubitemid 29299050)
32. Frommer K. W., Schäffler A., Büchler C., Adiponectin isoforms: a potential therapeutic target in rheumatoid arthritis? Annals of the Rheumatic Diseases 2012 71 10 1724 1732 10.1136/annrheumdis-2011-200924
33. Baratta R., Amato S., Degano C., Farina M. G., Patanè G., Vigneri R., Frittitta L., Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2665 2671 2-s2.0-2942670648 10.1210/jc.2003-031777 (Pubitemid 38766347)
34. Hung J., McQuillan B. M., Thompson P. L., Beilby J. P., Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. International Journal of Obesity 2008 32 5 772 779 2-s2.0-43449090395 10.1038/sj.ijo.0803793 (Pubitemid 351670618)
35. Dekker J. M., Funahashi T., Nijpels G., Pilz S., Stehouwer C. D. A., Snijder M. B., Bouter L. M., Matsuzawa Y., Shimomura I., Heine R. J., Prognostic value of adiponectin for cardiovascular disease and mortality. Journal of Clinical Endocrinology and Metabolism 2008 93 4 1489 1496 2-s2.0-42049085890 10.1210/jc.2007-1436 (Pubitemid 351519753)
36. Li S., Shin H. J., Ding E. L., van Dam R. M., Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. The Journal of the American Medical Association 2009 302 2 179 188 2-s2.0-67650169799 10.1001/jama.2009.976
37. Tucholski K., Otto-Buczkowska E., The role of leptin in the regulation of carbohydrate metabolism. Polish Journal of Endocrinology 2011 62 3 258 262 2-s2.0-79960818482
38. Tabara Y., Osawa H., Kawamoto R., Tachibana-Iimori R., Yamamoto M., Nakura J., Miki T., Makino H., Kohara K., Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami health promoting program study. Journal of Clinical Endocrinology and Metabolism 2008 93 3 715 722 2-s2.0-40849094268 10.1210/jc.2007-0397 (Pubitemid 351398544)
39. Rizza S., Gigli F., Galli A., Micchelini B., Lauro D., Lauro R., Federici M., Adiponectin isoforms in elderly patients with or without coronary artery disease. Journal of the American Geriatrics Society 2010 58 4 702 706 2-s2.0-77950380869 10.1111/j.1532-5415.2010.02773.x
40. Nakashima R., Yamane K., Kamei N., Nakanishi S., Kohno N., Low serum levels of total and high-molecular-weight adiponectin predict the development of metabolic syndrome in Japanese-Americans. Journal of Endocrinological Investigation 2011 34 8 615 619 2-s2.0-80053637414 10.3275/7409
41. Graessler J., Gruber M., Radke R., Kopprasch S., Schwarz P. E. H., Kamke W., Bornstein S. R., Fischer S., Type 2 diabetes in octogenarians is associated with decreased low molecular weight adiponectin. Gerontology 2011 57 4 316 326 2-s2.0-79959655026 10.1159/000316575
42. Moschen A. R., Kaser A., Enrich B., Mosheimer B., Theurl M., Niederegger H., Tilg H., Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. Journal of Immunology 2007 178 3 1748 1758 2-s2.0-33846527541 (Pubitemid 46154646)
43. Wang P., van Greevenbroek M. M. J., Bouwman F. G., Brouwers M. C. G. J., van der Kallen C. J. H., Smit E., Keijer J., Mariman E. C. M., The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile. Pflügers Archiv 2007 454 6 971 976 2-s2.0-34548315745 10.1007/s00424-007- 0262-y (Pubitemid 47338462)
44. Sentinelli F., Romeo S., Arca M., Filippi E., Leonetti F., Banchieri M., Di Mario U., Baroni M. G., Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. Diabetes 2002 51 3 860 862 2-s2.0-0036314156 (Pubitemid 34760201)
45. Degawa-Yamauchi M., Bovenkerk J. E., Juliar B. E., Watson W., Kerr K., Jones R., Zhu Q., Considine R. V., Serum resistin (FIZZ3) protein is increased in obese humans. Journal of Clinical Endocrinology and Metabolism 2003 88 11 5452 5455 2-s2.0-0344874247 10.1210/jc.2002-021808 (Pubitemid 37452753)
46. Lee J. H., Chan J. L., Yiannakouris N., Kontogianni M., Estrada E., Seip R., Orlova C., Mantzoros C. S., Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. Journal of Clinical Endocrinology and Metabolism 2003 88 10 4848 4856 2-s2.0-0242320395 10.1210/jc.2003-030519 (Pubitemid 37357535)
47. Heilbronn L. K., Rood J., Janderova L., Albu J. B., Kelley D. E., Ravussin E., Smith S. R., Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. Journal of Clinical Endocrinology and Metabolism 2004 89 4 1844 1848 2-s2.0-1942504927 10.1210/jc.2003-031410 (Pubitemid 38507943)
48. Vozarova de Courten B., Degawa-Yamauchi M., Considine R. V., Tataranni P. A., High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 2004 53 5 1279 1284 (Pubitemid 38569014)
49. Reilly M. P., Lehrke M., Wolfe M. L., Rohatgi A., Lazar M. A., Rader D. J., Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005 111 7 932 939 2-s2.0-14044257211 10.1161/01.CIR.0000155620.10387.43 (Pubitemid 40279897)
50. Hivert M. F., Sullivan L. M., Fox C. S., Nathan D. M., D'Agostino R. B. Sr., Wilson P. W. F., Meigs J. B., Associations of adiponectin, resistin, and tumor necrosis factor- α with insulin resistance. Journal of Clinical Endocrinology and Metabolism 2008 93 8 3165 3172 2-s2.0-49249138836 10.1210/jc.2008-0425
51. Beckers S., Zegers D., van Camp J. K., Boudin E., Nielsen T. L., Brixen K., Andersen M., van Hul W., Resistin polymorphisms show associations with obesity, but not with bone parameters in men: results from the odense androgen study. Molecular Biology Reports 2013 40 3 2467 2472 10.1007/s11033-012-2327-z
52. Ramos E. J. B., Xu Y., Romanova I., Middleton F., Chen C., Quinn R., Inui A., Das U., Meguid M. M., Is obesity an inflammatory disease? Surgery 2003 134 2 329 335 2-s2.0-0042328038 10.1067/msy.2003.267 (Pubitemid 37070357)
53. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor- α: direct role in obesity-linked insulin resistance. Science 1993 259 5091 87 91 2-s2.0-0027459878 (Pubitemid 23036092)
54. Aviña-Zubieta J. A., Choi H. K., Sadatsafavi M., Etminan M., Esdaile J. M., Lacaille D., Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Care and Research 2008 59 12 1690 1697 2-s2.0-57149096904 10.1002/art.24092
55. Otero M., Logo R., Gomez R., Logo F., Dieguez C., Gómez-Reino J. J., Gualillo O., Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2006 65 9 1198 1201 2-s2.0-33747786726 10.1136/ard.2005.046540 (Pubitemid 44277396)
56. Lee S. W., Park M. C., Park Y. B., Lee S. K., Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatology International 2007 27 6 537 540 2-s2.0-33947137320 10.1007/s00296-006-0253-x (Pubitemid 46411889)
57. Schäffler A., Ehling A., Neumann E., Herfarth H., Tarner I., Schölmerich J., Müller-Ladner U., Gay S., Adipocytokines in synovial fluid. The Journal of the American Medical Association 2003 290 13 1709 1710 2-s2.0-0141816765 10.1001/jama.290.13.1709-c
58. Kenchaiah S., Evans J. C., Levy D., Wilson P. W. F., Benjamin E. J., Larson M. G., Kannel W. B., Vasan R. S., Obesity and the risk of heart failure. The New England Journal of Medicine 2002 347 5 305 313 2-s2.0-0036681988 10.1056/NEJMoa020245 (Pubitemid 34815352)
59. Yoda-Murakami M., Taniguchi M., Takahashi K., Kawamata S., Saito K., Choi-Miura N., Tomita M., Change in expression of GBP28/adiponectin in carbon tetrachloride-administrated mouse liver. Biochemical and Biophysical Research Communications 2001 285 2 372 377 2-s2.0-0034816307 10.1006/bbrc.2001.5134 (Pubitemid 32918080)
60. Berner H. S., Lyngstadaas S. P., Spahr A., Monjo M., Thommesen L., Drevon C. A., Syversen U., Reseland J. E., Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004 35 4 842 849 2-s2.0-5344272498 10.1016/j.bone.2004.06.008 (Pubitemid 39349215)
61. Delaigle A. M., Jonas J., Bauche I. B., Cornu O., Brichard S. M., Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 2004 145 12 5589 5597 2-s2.0-9444285912 10.1210/en.2004-0503 (Pubitemid 39564599)
62. Ehling A., Schäffler A., Herfarth H., The potential of adiponectin in driving arthritis. Journal of Immunology 2006 176 7 4468 4478 (Pubitemid 44264427)
63. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y., Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999 100 25 2473 2476 2-s2.0-0033613545 (Pubitemid 30005109)
64. Frommer K. W., Zimmermann B., Meier F. M. P., Schröder D., Heil M., Schäffler A., Büchler C., Steinmeyer J., Brentano F., Gay S., Müller-Ladner U., Neumann E., Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis. Arthritis and Rheumatism 2010 62 10 2886 2899 2-s2.0-77957355863 10.1002/art.27616
65. Choi H. M., Lee Y. A., Lee S. H., Hong S., Hahm D., Choi S., Yang H., Yoo M. C., Kim K. S., Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators. Arthritis Research and Therapy 2009 11 6, article R161 2-s2.0-77952490138 10.1186/ar2844
66. Chung C. P., Oeser A., Solus J. F., Gebretsadik T., Shintani A., Avalos I., Sokka T., Raggi P., Pincus T., Stein C. M., Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis and Rheumatism 2008 58 7 2105 2112 2-s2.0-47249158092 10.1002/art.23600 (Pubitemid 351988102)
67. Busso N., So A., Chobaz-Péclat V., Morard C., Martinez-Soria E., Talabot-Ayer D., Gabay C., Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. Journal of Immunology 2002 168 2 875 882 2-s2.0-0037080196 (Pubitemid 34049591)
68. Lord G. M., Matarese G., Howard J. K., Baker R. J., Bloom S. R., Lechler R. I., Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998 394 6696 897 901 2-s2.0-0032572722 10.1038/29795 (Pubitemid 28410912)
69. Bokarewa M., Nagaev I., Dahlberg L., Smith U., Tarkowski A., Resistin, an adipokine with potent proinflammatory properties. Journal of Immunology 2005 174 9 5789 5795 2-s2.0-17844392652 (Pubitemid 40593223)
70. Meier F. M., Frommer K. W., Peters M. A., Brentano F., Lefèvre S., Schröder D., Kyburz D., Steinmeyer J., Rehart S., Gay S., Müller-Ladner U., Neumann E., Visfatin/pre-B cell colony-enhancing factor (PBEF): a proinflammatory and cell motility-changing factor in rheumatoid arthritis. The Journal of Biological Chemistry 2012 287 34 28378 28385 10.1074/jbc.M111.312884
71. Escalante A., Haas R. W., del Rincón I., Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Archives of Internal Medicine 2005 165 14 1624 1629 2-s2.0-23744474780 10.1001/archinte.165.14.1624 (Pubitemid 41124157)
72. Elkan A. C., Engvall I. L., Cederholm T., Hafström I., Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, mini nutritional assessment and body composition techniques. European Journal of Nutrition 2009 48 5 315 322 2-s2.0-70349573763 10.1007/s00394-009-0017-y
73. Dessein P. H., Joffe B. I., Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis and Rheumatism 2006 54 9 2765 2775 2-s2.0-33749323030 10.1002/art.22053 (Pubitemid 44497755)
74. Pearson T. A., Mensah G. A., Alexander R. W., Anderson J. L., Cannon R. O. III, Criqui M., Fadl Y. Y., Fortmann S. P., Hong Y., Myers G. L., Rifai N., Smith S. C. Jr., Taubert K., Tracy R. P., Vinicor F., Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 2003 107 3 499 511 2-s2.0-0037469232 10.1161/01.CIR.0000052939.59093.45 (Pubitemid 36158056)
75. Tomizawa A., Hattori Y., Kasai K., Nakano Y., Adiponectin induces NF- B activation that leads to suppression of cytokine-induced NF- B activation in vascular endothelial cells: globular adiponectin versus high molecular weight adiponectin. Diabetes and Vascular Disease Research 2008 5 2 123 127 2-s2.0-45249085983 10.3132/dvdr.2008.020 (Pubitemid 351839284)
76. Hattori Y., Nakano Y., Hattori S., Tomizawa A., Inukai K., Kasai K., High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF- B activation in vascular endothelial cells. FEBS Letters 2008 582 12 1719 1724 2-s2.0-43549093962 10.1016/j.febslet.2008.04.037
77. Ebina K., Fukuhara A., Ando W., Hirao M., Koga T., Oshima K., Matsuda M., Maeda K., Nakamura T., Ochi T., Shimomura I., Yoshikawa H., Hashimoto J., Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction. Clinical Rheumatology 2009 28 4 445 451 2-s2.0-61549094357 10.1007/s10067-008-1074-y
78. Giles J. T., van der Heijde D. M., Bathon J. M., Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis. Annals of the Rheumatic Diseases 2011 70 9 1562 1568 2-s2.0-80051474980 10.1136/ard.2011.150813
79. Klein-Wieringa I. R., van der Linden M. P. M., Knevel R., Kwekkeboom J. C., van Beelen E., Huizinga T. W. J., van der Helm-Van Mil A., Kloppenburg M., Toes R. E. M., Ioan-Facsinay A., Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis. Arthritis and Rheumatism 2011 63 9 2567 2574 2-s2.0-80052314683 10.1002/art.30449
80. Luo X. H., Guo L. J., Xie H., Yuan L., Wu X., Zhou H., Liao E., Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. Journal of Bone and Mineral Research 2006 21 10 1648 1656 2-s2.0-33749244468 10.1359/jbmr.060707 (Pubitemid 44484610)
81. Alonzi T., Fattori E., Lazzaro D., Costa P., Probert L., Kollias G., de Benedetti F., Poli V., Ciliberto G., Interleukin 6 is required for the development of collagen-induced arthritis. Journal of Experimental Medicine 1998 187 4 461 468 2-s2.0-0032536542 10.1084/jem.187.4.461 (Pubitemid 28093348)
82. Gabay C., Interleukin-6 and chronic inflammation. Arthritis Research and Therapy 2006 8 supplement 2, article S3 2-s2.0-33748121115 10.1186/ar1917
83. Härle P., Sarzi-Puttini P., Cutolo M., Straub R. H., No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2006 65 7 970 971 2-s2.0-33745728464 10.1136/ard.2005.040857
84. Laurberg T. B., Frystyk J., Ellingsen T., Hansen I. T., Jørgensen A., Tarp U., Hetland M. L., Hørslev-Petersen K., Hornung N., Poulsen J. H., Flyvbjerg A., Stengaard-Pedersen K., Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls. Journal of Rheumatology 2009 36 9 1885 1891 2-s2.0-70349237770 10.3899/jrheum.080907
85. Giles J. T., Allison M., Bingham C. O. III, Scott W. M. Jr., Bathon J. M., Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Care and Research 2009 61 9 1248 1256 2-s2.0-69749093928 10.1002/art.24789
86. van der Helm-van Mil A. H. M., van der Kooij S. M., Allaart C. F., Toes R. E. M., Huizinga T. W. J., A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Annals of the Rheumatic Diseases 2008 67 6 769 774 2-s2.0-45149103799 10.1136/ard.2007.078832 (Pubitemid 351829376)
87. Kopp H. P., Krzyzanowska K., Möhlig M., Spranger J., Pfeiffer A. F. H., Schernthaner G., Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. International Journal of Obesity 2005 29 7 766 771 2-s2.0-21244472681 10.1038/sj.ijo.0802983 (Pubitemid 40897012)
88. Anders H. J., Rihl M., Heufelder A., Loch O., Schattenkirchner M., Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism 1999 48 6 745 748 2-s2.0-0033002314 10.1016/S0026-0495(99)90174-9 (Pubitemid 29277646)
89. Popa C., Netea M. G., Radstake T. R. D. S., van Riel P. L., Barrera P., van der Meer J. W. M., Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Annals of the Rheumatic Diseases 2005 64 8 1195 1198 2-s2.0-23444462627 10.1136/ard.2004.032243 (Pubitemid 41113356)
90. Hizmetli S., Kisa M., Gokalp N., Bakici M. Z., Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis? Rheumatology International 2007 27 4 335 338 2-s2.0-33846304699 10.1007/s00296-006-0264-7 (Pubitemid 46122275)
91. Wisłowska M., Rok M., Jaszczyk B., Stpień K., Cicha M., Serum leptin in rheumatoid arthritis. Rheumatology International 2007 27 10 947 954 2-s2.0-34447509884 10.1007/s00296-007-0335-4 (Pubitemid 47084243)
92. Salazar-Páramo M., González-Ortiz M., González- López L., Serum leptin levels in patients with rheumatoid arthritis. Journal of Clinical Rheumatology 2001 7 1 57 59 (Pubitemid 32172772)
93. Bokarewa M., Bokarew D., Hultgren O., Tarkowski A., Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2003 62 10 952 956 2-s2.0-0141762514 10.1136/ard.62.10.952 (Pubitemid 37159493)
94. Toussirot É., Nguyen N. U., Dumoulin G., Aubin F., Cédoz J., Wendling D., Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology 2005 44 1 120 125 2-s2.0-12344334651 10.1093/rheumatology/keh421 (Pubitemid 40124344)
95. Rho Y. H., Solus J., Sokka T., Oeser A., Chung C. P., Gebretsadik T., Shintani A., Pincus T., Stein C. M., Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis and Rheumatism 2009 60 7 1906 1914 2-s2.0-67650066805 10.1002/art.24626
96. Olama S. M., Senna M. K., Elarman M., Synovial/serum leptin ratio in rheumatoid arthritis: the association with activity and erosion. Rheumatology International 2012 32 3 683 690 2-s2.0-78649688822 10.1007/s00296-010-1698-5
97. Gabay C., Dreyer M. G., Pellegrinelli N., Chicheportiche R., Meier C. A., Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. Journal of Clinical Endocrinology and Metabolism 2001 86 2 783 791 2-s2.0-0035095953 10.1210/jc.86.2.783 (Pubitemid 32207497)
98. Cohen S., Hurd E., Cush J., Schiff M., Weinblatt M. E., Moreland L. W., Kremer J., Bear M. B., Rich W. J., McCabe D., Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatism 2002 46 3 614 624 2-s2.0-0036190776 10.1002/art.10141 (Pubitemid 34214243)
99. Rho Y. H., Chung C. P., Solus J. F., Raggi P., Oeser A., Gebretsadik T., Shintani A., Stein C. M., Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis. Arthritis and Rheumatism 2010 62 5 1259 1264 2-s2.0-77951710438 10.1002/art.27376
100. Šenolt L., Housa D., Vernerová Z., Jirásek T., Svobodová R., Veigl D., Anderlová K., Müller-Ladner U., Pavelka K., Haluzík M., Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Annals of the Rheumatic Diseases 2007 66 4 458 463 2-s2.0-34147205638 10.1136/ard.2006.054734 (Pubitemid 46580464)
101. Klaasen R., Herenius M. M. J., Wijbrandts C. A., de Jager W., van Tuyl L. H., Nurmohamed M. T., Prakken B. J., Gerlag D. M., Tak P. P., Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis. Annals of the Rheumatic Diseases 2012 71 9 1510 1516 2-s2.0-84858725710 10.1136/annrheumdis-2011-200646
102. Bijlsma J. W. J., Berenbaum F., Lafeber F. P. J. G., Osteoarthritis: an update with relevance for clinical practice. The Lancet 2011 377 9783 2115 2126 2-s2.0-79959341732 10.1016/S0140-6736(11)60243-2
103. Alexopoulos L. G., Youn I., Bonaldo P., Guilak F., Developmental and osteoarthritic changes in Col6a1-knockout mice: biomechanics of type VI collagen in the cartilage pericellular matrix. Arthritis and Rheumatism 2009 60 3 771 779 2-s2.0-61649119401 10.1002/art.24293
104. Iliopoulos D., Malizos K. N., Tsezou A., Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Annals of the Rheumatic Diseases 2007 66 12 1616 1621 2-s2.0-36549024994 10.1136/ard.2007.069377 (Pubitemid 350205450)
105. Yusuf E., Nelissen R. G., Ioan-Facsinay A., Stojanovic-Susulic V., DeGroot J., van Osch G., Middeldorp S., Huizinga T. W. J., Kloppenburg M., Association between weight or body mass index and hand osteoarthritis: a systematic review. Annals of the Rheumatic Diseases 2010 69 4 761 765 2-s2.0-77950302564 10.1136/ard.2008.106930
106. Hui W., Litherland G. J., Elias M. S., Kitson G. I., Cawston T. E., Rowan A. D., Young D. A., Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases. Annals of the Rheumatic Diseases 2012 71 3 455 462 2-s2.0-84857239741 10.1136/annrheumdis-2011-200372
107. Liang J., Feng J., Wu W. K. K., Xiao J., Wu Z., Han D., Zhu Y., Qiu G., Leptin-mediated cytoskeletal remodeling in chondrocytes occurs via the RhoA/ROCK pathway. Journal of Orthopaedic Research 2011 29 3 369 374 2-s2.0-79251539589 10.1002/jor.21257
108. Griffin T. M., Fermor B., Huebner J. L., Kraus V. B., Rodriguiz R. M., Wetsel W. C., Cao L., Setton L. A., Guilak F., Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice. Arthritis Research and Therapy 2010 12 4, article R130 2-s2.0-78651417411 10.1186/ar3068
109. Simopoulou T., Malizos K. N., Iliopoulos D., Stefanou N., Papatheodorou L., Ioannou M., Tsezou A., Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis and Cartilage 2007 15 8 872 883 2-s2.0-34547676409 10.1016/j.joca.2007.01.018 (Pubitemid 47209251)
110. Tong K. M., Chen C. P., Huang K. C., Shieh D., Cheng H., Tzeng C., Chen K., Chiu Y., Tang C., Adiponectin increases MMP-3 expression in human chondrocytes through adipor1 signaling pathway. Journal of Cellular Biochemistry 2011 112 5 1431 1440 2-s2.0-79953690517 10.1002/jcb.23059
111. Kang E. H., Lee Y. J., Kim T. K., Chang C. B., Chung J., Shin K., Lee E. Y., Lee E. B., Song Y. W., Adiponectin is a potential catabolic mediator in osteoarthritis cartilage. Arthritis Research and Therapy 2010 12 6, article R231 2-s2.0-78650674502 10.1186/ar3218
112. Lago R., Gomez R., Otero M., Lago F., Gallego R., Dieguez C., Gomez-Reino J. J., Gualillo O., A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthritis and Cartilage 2008 16 9 1101 1109 2-s2.0-49149103250 10.1016/j.joca.2007.12.008
113. Chen T. H., Chen L., Hsieh M. S., Chang C. P., Chou D. T., Tsai S. H., Evidence for a protective role for adiponectin in osteoarthritis. Biochimica et Biophysica Acta 2006 1762 8 711 718 2-s2.0-33747886896 10.1016/j.bbadis.2006.06. 008 (Pubitemid 44293372)
114. Gosset M., Berenbaum F., Salvat C., Sautet A., Pigenet A., Tahiri K., Jacques C., Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. Arthritis and Rheumatism 2008 58 5 1399 1409 2-s2.0-43949131087 10.1002/art.23431 (Pubitemid 351705929)
115. Yammani R. R., Loeser R. F., Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes. Arthritis Research and Therapy 2012 14 1, article R23 2-s2.0-84856291934 10.1186/ar3705
116. Lee J. H., Ort T., Ma K., Picha K., Carton J., Marsters P. A., Lohmander L. S., Baribaud F., Song X. R., Blake S., Resistin is elevated following traumatic joint injury and causes matrix degradation and release of inflammatory cytokines from articular cartilage in vitro. Osteoarthritis and Cartilage 2009 17 5 613 620 2-s2.0-64849117486 10.1016/j.joca.2008.08.007
117. Klein-Wieringa I. R., Kloppenburg M., Bastiaansen-Jenniskens Y. M., Yusuf E., Kwekkeboom J. C., El-Bannoudi H., Nelissen R. G. H. H., Zuurmond A., Stojanovic-Susulic V., van Osch G. J. V. M., Toes R. E. M., Ioan-Facsinay A., The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Annals of the Rheumatic Diseases 2011 70 5 851 857 2-s2.0-79953297921 10.1136/ard.2010.140046
118. Clockaerts S., Bastiaansen-Jenniskens Y. M., Feijt C., de Clerck L., Verhaar J. A. N., Zuurmond A., Stojanovic-Susulic V., Somville J., Kloppenburg M., van Osch G. J. V. M., Cytokine production by infrapatellar fat pad can be stimulated by interleukin 1 β and inhibited by peroxisome proliferator activated receptor α agonist. Annals of the Rheumatic Diseases 2012 71 6 1012 1018 2-s2.0-84856446524 10.1136/annrheumdis-2011-200688
119. Berry P. A., Jones S. W., Cicuttini F. M., Wluka A. E., MacIewicz R. A., Temporal relationship between serum adipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with clinical knee osteoarthritis. Arthritis and Rheumatism 2011 63 3 700 707 2-s2.0-79953701048 10.1002/art.30182
120. Ku J. H., Lee C. K., Joo B. S., An B. M., Choi S. H., Wang T. H., Cho H. L., Correlation of synovial fluid leptin concentrations with the severity of osteoarthritis. Clinical Rheumatology 2009 28 12 1431 1435 2-s2.0-70450255129 10.1007/s10067-009-1242-8
121. Karvonen-Gutierrez C. A., Harlow S. D., Mancuso P., Jacobson J., de Leon C. F. M., Nan B., Association of leptin levels with radiographic knee osteoarthritis among a cohort of midlife women. Arthritis Care and Research 2013 65 6 936 944 10.1002/acr.21922
122. Honsawek S., Chayanupatkul M., Correlation of plasma and synovial fluid adiponectin with knee osteoarthritis severity. Archives of Medical Research 2010 41 8 593 598 2-s2.0-78650727090 10.1016/j.arcmed.2010.11.007
123. Yusuf E., Ioan-Facsinay A., Bijsterbosch J., Klein-Wieringa I., Kwekkeboom J., Slagboom P. E., Huizinga T. W. J., Kloppenburg M., Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis. Annals of the Rheumatic Diseases 2011 70 7 1282 1284 2-s2.0-79957629294 10.1136/ard.2010.146282
124. Filková M., Lisková M., Hulejová H., Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis. Annals of the Rheumatic Diseases 2009 68 2 295 296 10.1136/ard.2008.095737
125. Koskinen A., Juslin S., Nieminen R., Moilanen T., Vuolteenaho K., Moilanen E., Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Research and Therapy 2011 13 6, article R184 2-s2.0-81055126964 10.1186/ar3512
126. Choe J. Y., Bae J., Jung H. Y., Park S. H., Lee H. J., Kim S. K., Serum resistin level is associated with radiographic changes in hand osteoarthritis: cross-sectional study. Joint Bone Spine 2012 79 2 160 165 2-s2.0-84856412071 10.1016/j.jbspin.2011.04.009
127. de Boer T. N., van Spil W. E., Huisman A. M., Polak A. A., Bijlsma J. W., Lafeber F. P., Mastbergen S. C., Serum adipokines in osteoarthritis, comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthritis and Cartilage 2012 20 8 846 853 10.1016/j.joca.2012.05.002